MeiraGTx Holdings plc

MGTX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
Revenue $81.4M $33.3M $14.0M $15.9M $37.7M $15.6M $13.3M
Cost of Revenue — — — — — — —
Gross Profit — — — — — — —
Gross Margin — — — — — — —
Operating Expenses
Research & Development $129.6M $119.5M $103.8M $85.7M $66.7M $33.9M $24.9M
SG&A Expense $52.9M $54.2M $47.3M $46.6M $43.8M $44.2M $46.7M
Operating Income $-106.0M $-164.2M $-137.1M $-116.4M $-72.8M $-62.6M $-58.3M
Operating Margin -130.2% -493.4% -977.8% -730.9% -193.0% -401.9% -438.4%
Interest Expense $12.2M $13.3M $13.2M $4.9M $288.0K $139.0K $48.6K
Pretax Income $-114.2M $-147.8M $-84.0M $-129.6M $-79.6M $-58.0M $-54.7M
Income Tax Expense $0 $0 $0 — $0 $0 $0
Net Income $-114.2M $-147.8M $-84.0M $-129.6M $-79.6M $-58.0M $-54.7M
Net Margin -140.3% -444.1% -599.5% -814.2% -211.0% -372.6% -411.9%
EPS (Basic) $-1.42 $-2.12 $-1.49 $-2.87 $-1.80 $-1.54 $-1.65
EPS (Diluted) $-1.42 $-2.12 $-1.49 $-2.87 $-1.80 $-1.54 $-1.65
Shares Outstanding (Basic) 80.4M 69.8M 56.5M 45.2M 44.1M 37.7M 36.8M
Shares Outstanding (Diluted) 80.4M 69.8M 56.5M 45.2M 44.1M 37.7M 36.8M
Dividends Per Share — — — — — — —